A phase I trial of AB-729
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2018
At a glance
- Drugs AB-729 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; First in man
- 09 Oct 2018 According to an Arbutus Biopharma media release, the company expects to initiate this trial in Q2 2019.
- 10 May 2018 Indication assumed based on Research program profile. Also assumed subjects to be adult volunteers since this is the first phase I trial.
- 10 May 2018 New trial record